Abstract
Background
An elevation of cardiac biomarkers is observed after intense or long-lasting physical activity. However, a recent meta-analysis has suggested that there might be an inverse relationship between duration of exercise and degree of biomarker elevation. The objective of this observational study was to investigate the impact of ultra-marathon (UM) vs. marathon (M) on biomarkers of myocyte necrosis and hemodynamic stress/congestion.
Methods
Well-trained endurance athletes were recruited to participate in a 130-km UM and a M run. Troponin I (TnI), creatine kinase (CK), N-terminal pro-brain natriuretic peptide (NT-proBNP), mid-regional pro-adrenomedullin (MR-proADM), and copeptin were measured after both events, respectively.
Results
Fifteen athletes (14 males, one female) were included. There was no difference in exercise intensity according to the Borg scale (UM 16 [IQR 15–17], M 16 [IQR 14–17]; p = 0.424). Biomarkers of myocyte necrosis both differed significantly with higher levels of TnI (UM 0.056 ng/L [IQR 0.022–0.104), M 0.028 ng/L [IQR 0.022–0.049]; p = 0.016) and CK (UM 6992 U/l [IQR 2886–23038], M 425 U/l [IQR 327–681]; p = 0.001) after UM compared to M. Also, NT-proBNP (UM 723 ng/L [IQR 378–1152], M 132 ng/L [IQR 64–198]; p = 0.001) and MR-proADM (UM 1.012 nmol/L [IQR 0.753–0.975], M 0.877 nmol/L [IQR 0.550–0.985]; p = 0.023) as markers of myocardial congestion were significantly higher after UM. There was a tendency for elevated copeptin levels after M, but did not reach statistical significance (p = 0.078).
Conclusion
Ultra-marathon is associated with higher levels of biomarkers of myocyte necrosis and cardiac congestion compared to marathon, highlighting the impact of exercise duration on the cardiovascular system.
Similar content being viewed by others
References
Boulé NG, Haddad E, Kenny GP et al (2001) Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218–1227
Kelley G (2004) Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med (Baltim) 38:651–661. https://doi.org/10.1016/j.ypmed.2003.12.012
Börjesson M, Onerup A, Lundqvist S, Dahlöf B (2016) Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs. Br J Sports Med 50:356–361. https://doi.org/10.1136/bjsports-2015-095786
Tanasescu M, Leitzmann MF, Rimm EB et al (2002) Exercise type and intensity in relation to coronary heart disease in men. JAMA 288:1994–2000
Scheer V (2019) Participation trends of ultra endurance events. Sports Med Arthrosc 27:3–7. https://doi.org/10.1097/JSA.0000000000000198
Dawson E, George K, Shave R et al (2003) Does the human heart fatigue subsequent to prolonged exercise? Sport Med 33:365–380
La Gerche A, Heidbuchel H (2014) Can intensive exercise harm the heart? You can get too much of a good thing. Circulation 130:992–1002. https://doi.org/10.1161/CIRCULATIONAHA.114.008141
Shave R, Baggish A, George K et al (2010) Exercise-induced cardiac troponin elevation. J Am Coll Cardiol 56:169–176. https://doi.org/10.1016/j.jacc.2010.03.037
Siegel AJ, Silverman LM, Evans WJ (1983) Elevated skeletal muscle creatine kinase MB isoenzyme levels in marathon runners. JAMA 250:2835–2837
Vargas KG, Kassem M, Mueller C et al (2016) Copeptin for the early rule-out of non-ST-elevation myocardial infarction. Int J Cardiol 223:797–804. https://doi.org/10.1016/j.ijcard.2016.08.304
Neilan TG, Januzzi JL, Lee-Lewandrowski E et al (2006) Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation 114:2325–2333. https://doi.org/10.1161/CIRCULATIONAHA.106.647461
Breuckmann F, Möhlenkamp S, Nassenstein K et al (2009) Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 251:50–57. https://doi.org/10.1148/radiol.2511081118
Mohlenkamp S, Lehmann N, Breuckmann F et al (2008) Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 29:1903–1910. https://doi.org/10.1093/eurheartj/ehn163
Gresslien T, Agewall S (2016) Troponin and exercise. Int J Cardiol 221:609–621. https://doi.org/10.1016/j.ijcard.2016.06.243
Shave R, George KP, Atkinson G et al (2007) Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc 39:2099–2106. https://doi.org/10.1249/mss.0b013e318153ff78
Eijsvogels TMH, Hoogerwerf MD, Oudegeest-Sander MH et al (2014) The impact of exercise intensity on cardiac troponin I release. Int J Cardiol 171:e3–e4. https://doi.org/10.1016/j.ijcard.2013.11.050
Eijsvogels T, George K, Shave R et al (2010) Effect of prolonged walking on cardiac troponin levels. Am J Cardiol 105:267–272. https://doi.org/10.1016/j.amjcard.2009.08.679
Lara B, Salinero JJ, Gallo-Salazar C et al (2019) Elevation of cardiac troponins after endurance running competitions. Circulation 139:709–711. https://doi.org/10.1161/CIRCULATIONAHA.118.034655
Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381
Eijsvogels TMH, Fernandez AB, Thompson PD (2016) Are there deleterious cardiac effects of acute and chronic endurance exercise? Physiol Rev 96:99–125. https://doi.org/10.1152/physrev.00029.2014
Feng J, Schaus BJ, Fallavollita JA et al (2001) Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103:2035–2037. https://doi.org/10.1161/01.cir.103.16.2035
Boström P, Mann N, Wu J et al (2010) C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143:1072–1083. https://doi.org/10.1016/j.cell.2010.11.036
Abdulla J, Nielsen JR (2009) Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace 11:1156–1159. https://doi.org/10.1093/europace/eup197
Baldesberger S, Bauersfeld U, Candinas R et al (2007) Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J 29:71–78. https://doi.org/10.1093/eurheartj/ehm555
La Gerche A, Burns AT, Mooney DJ et al (2012) Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 33:998–1006. https://doi.org/10.1093/eurheartj/ehr397
Andersen K, Farahmand B, Ahlbom A et al (2013) Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J 34:3624–3631. https://doi.org/10.1093/eurheartj/eht188
Scharhag J, Herrmann M, Urhausen A et al (2005) Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 150:1128–1134. https://doi.org/10.1016/j.ahj.2005.01.051
Rifai N, Douglas PS, O’Toole M et al (1999) Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol 83:1085–1089. https://doi.org/10.1016/S0002-9149(99)00020-X
Neumayr G, Pfister R, Mitterbauer G et al (2005) Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am J Cardiol 96:732–735. https://doi.org/10.1016/j.amjcard.2005.04.054
Siegel AJ, Silverman LM, Lopez RE (1980) Creatine kinase elevations in marathon runners: relationship to training and competition. Yale J Biol Med 53:275–279
Lippi G, Schena F, Salvagno GL et al (2015) Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon. J Clin Lab Anal 29:15–20. https://doi.org/10.1002/jcla.21720
Mingels AMA, Jacobs LHJ, Kleijnen VW et al (2010) Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance. Clin Res Cardiol 99:385–391. https://doi.org/10.1007/s00392-010-0134-x
Eijsvogels TMH, Hoogerwerf MD, Maessen MFH et al (2015) Predictors of cardiac troponin release after a marathon. J Sci Med Sport 18:88–92. https://doi.org/10.1016/j.jsams.2013.12.002
Wiese S, Breyer T, Dragu A et al (2000) Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102:3074–3079
Serrano-Ostáriz E, Terreros-Blanco JL, Legaz-Arrese A et al (2011) The impact of exercise duration and intensity on the release of cardiac biomarkers. Scand J Med Sci Sport 21:244–249. https://doi.org/10.1111/j.1600-0838.2009.01042.x
Morgenthaler NG, Struck J, Alonso C, Bergmann A (2005) Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823–1829. https://doi.org/10.1373/clinchem.2005.051110
Kato J, Kitamura K (2015) Bench-to-bedside pharmacology of adrenomedullin. Eur J Pharmacol 764:140–148
Masson S, Latini R, Carbonieri E et al (2010) The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial. Eur J Heart Fail 12:338–347. https://doi.org/10.1093/eurjhf/hfp206
Klip IT, Voors AA, Anker SD et al (2011) Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 97:892–898. https://doi.org/10.1136/hrt.2010.210948
Roffi M, Patrono C, Collet J-P et al (2015) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 32:2999–3054
Acknowledgements
This work was supported by the Association for the Promotion of Research on Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) and by the Ludwig Boltzmann Cluster for Cardiovascular Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest with this manuscript.
Rights and permissions
About this article
Cite this article
Wegberger, C., Tscharre, M., Haller, P.M. et al. Impact of ultra-marathon and marathon on biomarkers of myocyte necrosis and cardiac congestion: a prospective observational study. Clin Res Cardiol 109, 1366–1373 (2020). https://doi.org/10.1007/s00392-020-01634-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-020-01634-9